GM Discussion : September 22, 2003
GM Discussion : September 22, 2003
1. Conspiracy theorists
target British Govt
2. UK Royal Society in GM report
row
3. Costs decision upholds robust GM decision
making
4. Lost case costs MaDGE $24k
5. Qld scientists
target deadly disease
6. Boost for cane toad biocontrol
research
7. French growers will be swift to adopt
GM
8. Cancer vaccine potatoes developed
9. GM
agreement reached in Africa
10. Biotenz News Update - 19
September 2003
11. OGTR issues early-bird
notification
12. Biotech collapse may cost NZ $2b in GE
business
Conspiracy theorists target British Govt
The UK chapter of the conspiracy theorist’s club is abuzz with excitement over leaked letters it claims prove the British Government plans to support the commercial growing of genetically modified cr... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4820
UK Royal Society in GM report row
The British Government's GM crop trials have been hit by a scientific row after the Royal Society refused to publish a crucial report on the tests, Severin Carrell writes in the Independent.In one... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4819
Costs decision upholds robust GM decision making
The decision by the High Court at Auckland to award costs in favour of AgResearch following the judicial review of the decision to allow GM cattle experiments is a reinforcement of the regulatory proc... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4818
Lost case costs MaDGE $24k
The High Court has ordered Mothers Against Genetic Engineering to pay $24,000 in court costs after losing its GM cattle case against the Minister for the Environment, ERMA and AgResearch.The costs... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4817
Qld scientists target deadly disease
Scientists at the Queensland Institute of Medical Research are working to develop a vaccine to eradicate a potentially deadly disease which affects more than 250 million people each year.The resea... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4816
Boost for cane toad biocontrol research
Australia's Federal Government has set aside an extra $200,000 to fight cane toads.The funding is in addition to the $3.5 million the Commonwealth has already invested in research.The funding ... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4815
French growers will be swift to adopt GM
French maize farmers will be swift in adopting new genetically modified (GM) strains once regulatory hurdles are swept away under European Union law in the pipeline, officials from the main growers' a... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4814
Cancer vaccine potatoes developed
German scientists said last week they have genetically engineered potatoes to make a cancer-fighting vaccine. The researchers at the Institute of Plant Genetics and Crop Research in Gatersleben, G... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4813
GM agreement reached in Africa
Fourteen Southern Africa states have agreed to common guidelines on the regulation of genetically modified organisms and other products resulting from biotechnology.The 14 member states are Angola... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4812
Biotenz News Update - 19 September 2003
The latest issue of Biotenz News Update has been posted to the Biotenz website. Index:New Single Biotech Industry Organisation LaunchedMinister Announces Trans Tasman Biotech FundMP Annou... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4811
OGTR issues early-bird notification
Australia’s Gene Technology Regulator has issued notification of an up-coming chance to comment on the risk assessment and risk management plan for the intentional release of GM lupins into the enviro... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4810
Biotech collapse may cost NZ $2b in GE business
A subsidiary of the Government's biggest science company, Agresearch, yesterday declined to say how it will repair a biotech joint venture after the collapse of its partner. The failure has cast d... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4809
From the LSN news team
Francis Wevers - Executive Director
Christine Ross - Communications Assistant, Wellington